...
search icon
telo-img

Telomir Pharmaceuticals, Inc. Common Stock, Common Stock

TELO

NAQ

$5.03

+$0.09

(1.82%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$149.71M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
196.36K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.11 L
$9.39 H
$5.03

About Telomir Pharmaceuticals, Inc. Common Stock, Common Stock

Telomir Pharmaceuticals, Inc., a pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism. The company is developing Telomir 1, an oral small molecule metal ion regulator designed to extend telomere caps; maintain cellular balance; and combat oxidative stress that drives aging and disease progression. By modulating essential metal ions such as iron, and copper, Telomir-1 helps protect against age-related conditions, including Progeria, a rare genetic disorder that causes rapid aging in children; Wilson's disease, a genetic disorder leading to toxic copper buildup in the body; and Age-related Macular Degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameTELOSectorS&P500
1-Week Return21.5%-3.13%-2.45%
1-Month Return17.8%-1.22%-8.37%
3-Month Return-3.27%2.56%-7.53%
6-Month Return-17.13%-7.4%-0.54%
1-Year Return-30.33%-1.27%8.32%
3-Year Return-28.14%11.36%34.02%

Financials

Sep '21Sep '22Sep '23Sep '24
Total Revenue----[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Cost of Revenue--3.94M-[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Profit--(3.94M)-[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":-394204800,"profit":false},{"date":"2024-09-30","value":"-","profit":true}]
Gross Margin--(Infinity%)-[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":null,"profit":false},{"date":"2024-09-30","value":"-","profit":true}]
Operating Expenses138.13K854.15K3.94M11.87M[{"date":"2021-09-30","value":1.16,"profit":true},{"date":"2022-09-30","value":7.19,"profit":true},{"date":"2023-09-30","value":33.21,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Operating Income(138.13K)(854.15K)(3.94M)(12.24M)[{"date":"2021-09-30","value":-13813100,"profit":false},{"date":"2022-09-30","value":-85414700,"profit":false},{"date":"2023-09-30","value":-394204800,"profit":false},{"date":"2024-09-30","value":-1224217400,"profit":false}]
Total Non-Operating Income/Expense-3.00(10.77M)-[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":-359095500,"profit":false},{"date":"2024-09-30","value":"-","profit":true}]
Pre-Tax Income(138.13K)(854.15K)(13.07M)(16.53M)[{"date":"2021-09-30","value":-13813100,"profit":false},{"date":"2022-09-30","value":-85414700,"profit":false},{"date":"2023-09-30","value":-1307186400,"profit":false},{"date":"2024-09-30","value":-1653271600,"profit":false}]
Income Taxes(138.13K)(854.14K)(2.30M)(16.53M)[{"date":"2021-09-30","value":-13813200,"profit":false},{"date":"2022-09-30","value":-85414400,"profit":false},{"date":"2023-09-30","value":-229899900,"profit":false},{"date":"2024-09-30","value":-1653271600,"profit":false}]
Income After Taxes-(3.00)(10.77M)-[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2024-09-30","value":"-","profit":true}]
Income From Continuous Operations(138.13K)(854.15K)(13.07M)(16.53M)[{"date":"2021-09-30","value":-13813100,"profit":false},{"date":"2022-09-30","value":-85414700,"profit":false},{"date":"2023-09-30","value":-1307186400,"profit":false},{"date":"2024-09-30","value":-1653271600,"profit":false}]
Income From Discontinued Operations----[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income(138.13K)(854.15K)(13.07M)(16.53M)[{"date":"2021-09-30","value":-13813100,"profit":false},{"date":"2022-09-30","value":-85414700,"profit":false},{"date":"2023-09-30","value":-1307186400,"profit":false},{"date":"2024-09-30","value":-1653271600,"profit":false}]
EPS (Diluted)---(0.48)[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":-47.64,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TELO
Cash Ratio 1.86
Current Ratio 1.94

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TELO
ROA (LTM) -250.96%
ROE (LTM) -810.18%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TELO
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TELO
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 209.67
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Telomir Pharmaceuticals, Inc. Common Stock share price today?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) share price today is $5.03

Can Indians buy Telomir Pharmaceuticals, Inc. Common Stock shares?

Yes, Indians can buy shares of Telomir Pharmaceuticals, Inc. Common Stock (TELO) on Vested. To buy Telomir Pharmaceuticals, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TELO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Telomir Pharmaceuticals, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Telomir Pharmaceuticals, Inc. Common Stock (TELO) via the Vested app. You can start investing in Telomir Pharmaceuticals, Inc. Common Stock (TELO) with a minimum investment of $1.

How to invest in Telomir Pharmaceuticals, Inc. Common Stock shares from India?

You can invest in shares of Telomir Pharmaceuticals, Inc. Common Stock (TELO) via Vested in three simple steps:

  • Click on Sign Up or Invest in TELO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Telomir Pharmaceuticals, Inc. Common Stock shares
What is Telomir Pharmaceuticals, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is $9.39. The 52-week low price of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is $3.11.

What is Telomir Pharmaceuticals, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is 209.67

What is the Market Cap of Telomir Pharmaceuticals, Inc. Common Stock?

The market capitalization of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is $149.71M

What is Telomir Pharmaceuticals, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Telomir Pharmaceuticals, Inc. Common Stock is TELO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top